To further investigate the potential oncogenic roles of USP5-PD-L1 axis on lung cancer progression in vivo, we established mouse Lewis lung carcinoma cells (LLC) stably expressing control (Ctrl) or USP5 shRNA, in which the USP5 protein and mRNA were successfully knockdown (Fig. 4A). This evidence concerns the gene USP5 and lung cancer.